The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

Fri, 22nd Jan 2021 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

DEUTSCHE BANK RAISES LAND SECURITIES TO 'BUY' ('HOLD') - TARGET 730 PENCE

----------

DEUTSCHE BANK RAISES BRITISH LAND TO 'BUY' ('HOLD') - TARGET 490 PENCE

----------

PEEL HUNT INITIATES SAGE GROUP WITH 'BUY' - TARGET 735 PENCE

----------

CREDIT SUISSE CUTS SAGE GROUP PRICE TARGET TO 500 (530) PENCE - 'UNDERPERFORM'

----------

UBS RAISES SPIRAX-SARCO PRICE TARGET TO 12,000 (11,200) PENCE - 'NEUTRAL'

----------

UBS RAISES HALMA PRICE TARGET TO 2,550 (2,450) PENCE - 'NEUTRAL'

----------

HSBC RAISES ADMIRAL GROUP PRICE TARGET TO 2,800 PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES HARGREAVES LANSDOWN TARGET TO 1,700 (1,620) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES ENTAIN PRICE TARGET TO 1,601 (1,351) PENCE - 'BUY'

----------

JEFFERIES RAISES ENTAIN PRICE TARGET TO 1,500 (1,450) PENCE - 'BUY'

----------

BARCLAYS CUTS ASTRAZENECA PRICE TARGET TO 9,000 (9,300) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES ASTRAZENECA PRICE TARGET TO 6,575 (6,400) PENCE - 'SELL'

----------

CITIGROUP CUTS CRH TO 'NEUTRAL' (BUY) - PRICE TARGET 40 EUR

----------

BARCLAYS CUTS BUNZL TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 2,350 (2,750) PENCE

----------

RBC CUTS BHP GROUP PRICE TARGET TO 2,500 (2,600) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS POLYMETAL PRICE TARGET TO 2,520 (3,000) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES EVRAZ PRICE TARGET TO 460 (310) PENCE - 'SELL'

----------

JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1,563 (1,438) PENCE - 'NEUTRAL'

----------

SOCGEN RAISES BURBERRY PRICE TARGET TO 2,326 (2,160) PENCE - 'BUY'

----------

STIFEL EUROPE RAISES BURBERRY PRICE TARGET TO 2,150 (2,000) PENCE - 'BUY'

----------

FTSE 250

----------

DAVY RAISES EASYJET TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 920 (800) PENCE

----------

DAVY RAISES WIZZ AIR PRICE TARGET TO 4,000 (3,500) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES TUI PRICE TARGET TO 3 (1.51) EUR - 'SELL'

----------

UBS RAISES SPECTRIS PRICE TARGET TO 2,500 (2,300) PENCE - 'SELL'

----------

UBS RAISES ROTORK PRICE TARGET TO 372 (340) PENCE - 'BUY'

----------

UBS RAISES RENISHAW PRICE TARGET TO 4,100 (3,800) PENCE - 'SELL'

----------

UBS RAISES IMI PRICE TARGET TO 1,230 (1,130) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES CLOSE BROTHERS PRICE TARGET TO 1,480 (1,435) PENCE - 'HOLD'

----------

JPMORGAN RAISES CLOSE BROTHERS PRICE TARGET TO 1,500 (1,400) PENCE - 'NEUTRAL'

----------

RBC RAISES CLOSE BROTHERS PRICE TARGET TO 1,800 (1,600) PENCE - 'OUTPERFORM'

----------

HSBC RAISES DIRECT LINE PRICE TARGET TO 370 (368) PENCE - 'BUY'

----------

HSBC INITIATES XP POWER WITH 'BUY' - TARGET 6,100 PENCE

----------

HSBC INITIATES PREMIER FOODS WITH 'REDUCE' - TARGET 90 PENCE

----------

CITIGROUP CUTS VECTURA GROUP TO 'NEUTRAL' ('BUY') - TARGET 130 PENCE

----------

RBC RAISES UDG HEALTHCARE PRICE TARGET TO 940 (880) PENCE - 'OUTPERFORM'

----------

BARCLAYS CUTS 4IMPRINT GROUP PRICE TARGET TO 3,400 (3,500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES IBSTOCK PRICE TARGET TO 212 (203) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES QINETIQ PRICE TARGET TO 318 (305) PENCE - 'SELL'

----------

CREDIT SUISSE CUTS IWG PRICE TARGET TO 415 (425) PENCE - 'OUTPERFORM'

----------

BANK OF AMERICA RAISES ASCENTIAL PRICE TARGET TO 430 (420) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

HSBC INITIATES CARETECH WITH 'BUY' - TARGET 685 PENCE

----------

GOLDMAN SACHS RAISES LEARNING TECHNOLOGIES TARGET TO 124 (118.3) PENCE - 'SELL'

----------

BERENBERG RAISES LEARNING TECHNOLOGIES PRICE TARGET TO 230 (200) PENCE - 'BUY'

----------

UBS RAISES SOUTH32 PRICE TARGET TO 170 (165) PENCE - 'BUY'

----------

LIBERUM RAISES SUMO GROUP PRICE TARGET TO 385 (300) PENCE - 'BUY'

----------

LIBERUM RAISES TEAM17 PRICE TARGET TO 830 (750) PENCE - 'HOLD'

----------

HSBC RAISES NICHOLS PRICE TARGET TO 1,550 (1,500) PENCE - 'BUY'

----------

DAVY RAISES RYANAIR PRICE TARGET TO 18 (14.50) EUR - 'OUTPERFORM'

----------

LIBERUM INITIATES BANGO WITH 'BUY' - TARGET 260 PENCE

----------

BARCLAYS RAISES DAILY MAIL PRICE TARGET TO 740 (650) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN SACHS CUTS ASOS PRICE TARGET TO 5,800 (6,200) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
19 Mar 2021 09:46

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

Read more
18 Mar 2021 10:36

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

Read more
18 Mar 2021 07:43

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

Read more
11 Mar 2021 16:13

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Mar 2021 12:29

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
12 Jan 2021 08:16

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

Read more
30 Dec 2020 19:10

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Read more
29 Dec 2020 12:04

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Read more
29 Dec 2020 10:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.